JOHN WILEY & SONS, INC. (WLY) /
The revenue of JOHN WILEY & SONS, INC. over the past 10 years
Chart JOHN WILEY & SONS, INC.: revenue, fiscal 2017–2026 Open the chart →JOHN WILEY & SONS, INC. reported revenue of $1.68B in fiscal 2026, the latest fiscal year on file. In fiscal 2017 it was $1.72B — down 2.4% over 9 years. Year over year, revenue rose 5 times and fell 4 times. In these years the highest was $2.08B in fiscal 2022; the lowest $1.68B in fiscal 2026. The largest one-year move was in fiscal 2025: down 10%, from $1.87B to $1.68B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2026ended Apr 30, 2026 | $1.68B |
| 2025ended Apr 30, 2025 | $1.68B |
| 2024ended Apr 30, 2024 | $1.87B |
| 2023ended Apr 30, 2023 | $2.02B |
| 2022ended Apr 30, 2022 | $2.08B |
| 2021ended Apr 30, 2021 | $1.94B |
| 2020ended Apr 30, 2020 | $1.83B |
| 2019ended Apr 30, 2019 | $1.8B |
| 2018ended Apr 30, 2018 | $1.8B |
| 2017ended Apr 30, 2017 | $1.72B |
Fiscal years as JOHN WILEY & SONS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on JOHN WILEY & SONS, INC.
- The profitability of JOHN WILEY & SONS, INC.
- The cash flow of JOHN WILEY & SONS, INC.
- The debt of JOHN WILEY & SONS, INC.
- The dividends of JOHN WILEY & SONS, INC.
- All of JOHN WILEY & SONS, INC.'s financials, charted
Companies of a similar size
- BCCBoise Cascade Company
- SHAKSHAKE SHACK INC.
- LGNLegence Corp.
- FULFULLER H B CO
- ELVNENLIVEN THERAPEUTICS, INC.
Not investment advice. This page shows what JOHN WILEY & SONS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.